T cell-mediated immunity targeting polyomavirus BK

T cell-mediated immunity targeting polyomavirus BK - Not applicable

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

NL-OMON

Registry ID

NL-OMON37893

Enrollment

400

Registered

2012-05-15

Start date

2012-09-07

Completion date

Unknown

Last updated

2024-04-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

BK virus-associated nephropathy / BK virus-associated renal disease

Interventions

None listed

Eligibility

Age

18 Years to 99 Years

Inclusion criteria

Inclusion criteria: - Being a kidney transplant recipient treated according to the standard treatment protocols applying to kidney transplant recipients treated in the Academic medical Centre Amsterdam. - Age equal- to or older than eighteen years.

Exclusion criteria

Exclusion criteria: Age under eighteen years.

Design outcomes

Primary

Measure	Time frame
Numbers of BKV-specific T cells Phenotype of BKV-specific T cells Functional characteristics of BKV-specific T cells Identification of new epitopes on and in the BKV virion cytokines, chemokines and chemokine receptors in urine	—

Secondary

Measure	Time frame
the development of new tetramers through the identification of novel BKV epitopes.	—

Countries

Netherlands

Outcome results